# Maolac

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/maolac

- Industry: Biotechnology
- Headquarters: Yokneam, Israel
- Website: www.maolac.com
- Total disclosed funding: $3.2M
- Latest round: Seed (Jul 5, 2022)
- Investors on record: 6

## About

Based in Yokneam, Israel, and founded in 2018, Maolac operates as a bio-convergence platform for the discovery of proteins based on proprietary machine learning and natural language processing search algorithms. In July 2022, Maolac raised USD 3.2 million in seed funding led by OurCrowd, with participation from Mediterranean Towers Ventures, Naomi Investments, The Food Tech Lab, The Kitchen-FoodTech Hub, and Ventures Israel. As of July 2022, the company is led by its CEO, Maya Ashkenazi Otmazgin.

Maolac offers a proteomic prediction platform that combines advanced proteomics and NLP-based search algorithms to provide tailored functional milk proteins based on bio-similarity with breast milk. The company's platform uses a number of details: the biological indication, characterization of the biological pathway including proteins, properties, sensitivities, and end users(human, cat, or dog). Maolac has identified 1,500 different proteins for various applications.

The company plans to use the seed funding to develop technology to harness the benefits of breast milk and clinical trials and build a new production facility that can produce samples for customers.

## Funding rounds

- Seed, Jul 5, 2022, $3.2M — OurCrowd, Mediterranean Towers Ventures, The Kitchen - FoodTech Hub, Food Tech Lab, Ventures Israel, Naomi Investments

## Investors

- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Seed
- Mediterranean Towers Ventures (https://capitalatlas.ai/funds/mediterranean-towers-ventures) — Seed
- The Kitchen - FoodTech Hub — Seed
- Food Tech Lab (https://capitalatlas.ai/funds/food-tech-lab) — Seed
- Ventures Israel — Seed
- Naomi Investments — Seed